Nico Chen
Stock Analyst at DBS
(4.02)
# 1,754
Out of 5,125 analysts
126
Total ratings
59.5%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Nico Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $125 | $104.01 | +20.18% | 1 | Nov 5, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Initiated Coverage: Buy | $569.90 | $465.80 | +22.35% | 1 | Oct 29, 2026 | |
| HKG: 1530 3SBio Inc. | Initiated Coverage: Buy | $17.80 | $15.13 | +17.65% | 1 | Oct 15, 2026 | |
| PFE Pfizer | Reiterated: Buy | $30 → $35 | $29.36 | +19.21% | 3 | Oct 8, 2026 | |
| HKG: 2675 Shenzhen Edge Medical Co., Ltd. | Reiterated: Buy | $51.40 | $28.10 | +82.92% | 2 | Sep 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $240 → $270 | $280.78 | -3.84% | 9 | Sep 11, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 → $180 | $148.05 | +21.58% | 5 | Sep 11, 2026 | |
| MRNA Moderna | Reiterated: Hold | $45 → $150 | $250.83 | -40.20% | 4 | Sep 11, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,333 → $1,550 | $1,432.29 | +8.22% | 10 | Aug 25, 2026 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Reiterated: Buy | n/a | $21.18 | - | 3 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $170 | $144.12 | +17.96% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $480 | $450.04 | +6.66% | 1 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $101.59 | -11.41% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 | $324.29 | +38.76% | 1 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 140.00 → CHF 190.00 | CHF 133.60 | +42.22% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $183 → $230 | $293.89 | -21.74% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €59.00 → €52.00 | €42.94 | +21.10% | 3 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 650.51 → CHF 670.00 | CHF 661.00 | +1.36% | 4 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $100 | $83.65 | +19.55% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $320 | $412.55 | -22.43% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $400 | $465.23 | -14.02% | 6 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $700 → $910 | $916.06 | -0.66% | 2 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $540 | $547.89 | -1.44% | 1 | Jan 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23.40 → $36.00 | $49.62 | n/a | 9 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $48.23 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $125 | $170.87 | n/a | 2 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $212.61 | n/a | 5 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $504.42 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $44.70 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.08 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.80 | n/a | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,200 | ¥2,527 | n/a | 2 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.40 | $3.35 | n/a | 3 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.20 | n/a | 4 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $88.50 | n/a | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29.30 | $17.20 | n/a | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $29.06 | n/a | 2 | Nov 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $30 | $13.53 | n/a | 2 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €120.00 | €31.22 | n/a | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $189 | $345.80 | n/a | 1 | Aug 22, 2023 |
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $125
Current: $104.01
Upside: +20.18%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 29, 2026
Initiated Coverage: Buy
Price Target: $569.90
Current: $465.80
Upside: +22.35%
3SBio Inc.
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $17.80
Current: $15.13
Upside: +17.65%
Pfizer
Oct 8, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $29.36
Upside: +19.21%
Shenzhen Edge Medical Co., Ltd.
Sep 15, 2026
Reiterated: Buy
Price Target: $51.40
Current: $28.10
Upside: +82.92%
Johnson & Johnson
Sep 11, 2026
Reiterated: Hold
Price Target: $240 → $270
Current: $280.78
Upside: -3.84%
Merck & Co.
Sep 11, 2026
Reiterated: Buy
Price Target: $130 → $180
Current: $148.05
Upside: +21.58%
Moderna
Sep 11, 2026
Reiterated: Hold
Price Target: $45 → $150
Current: $250.83
Upside: -40.20%
Eli Lilly and Company
Aug 25, 2026
Reiterated: Buy
Price Target: $1,333 → $1,550
Current: $1,432.29
Upside: +8.22%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.18
Upside: -
Mar 18, 2026
Reiterated: Buy
Price Target: $175 → $170
Current: $144.12
Upside: +17.96%
Mar 18, 2026
Reiterated: Hold
Price Target: $480
Current: $450.04
Upside: +6.66%
Mar 18, 2026
Reiterated: Hold
Price Target: $90
Current: $101.59
Upside: -11.41%
Mar 18, 2026
Reiterated: Buy
Price Target: $450
Current: $324.29
Upside: +38.76%
Mar 17, 2026
Reiterated: Buy
Price Target: CHF 140.00 → CHF 190.00
Current: CHF 133.60
Upside: +42.22%
Feb 25, 2026
Reiterated: Hold
Price Target: $183 → $230
Current: $293.89
Upside: -21.74%
Feb 24, 2026
Reiterated: Buy
Price Target: €59.00 → €52.00
Current: €42.94
Upside: +21.10%
Feb 2, 2026
Reiterated: Buy
Price Target: CHF 650.51 → CHF 670.00
Current: CHF 661.00
Upside: +1.36%
Jan 28, 2026
Reiterated: Buy
Price Target: $80 → $100
Current: $83.65
Upside: +19.55%
Jan 28, 2026
Reiterated: Buy
Price Target: $265 → $320
Current: $412.55
Upside: -22.43%
Jan 22, 2026
Reiterated: Buy
Price Target: $365 → $400
Current: $465.23
Upside: -14.02%
Jan 22, 2026
Reiterated: Buy
Price Target: $700 → $910
Current: $916.06
Upside: -0.66%
Jan 19, 2026
Reiterated: Buy
Price Target: $540
Current: $547.89
Upside: -1.44%
Aug 26, 2025
Reiterated: Hold
Price Target: $23.40 → $36.00
Current: $49.62
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $66
Current: $48.23
Upside: n/a
May 30, 2025
Reiterated: Buy
Price Target: $100 → $125
Current: $170.87
Upside: n/a
May 21, 2025
Rated: Hold
Price Target: n/a
Current: $212.61
Upside: n/a
May 21, 2025
Rated: Hold
Price Target: n/a
Current: $504.42
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $130
Current: $44.70
Upside: n/a
Mar 3, 2025
Rated: Hold
Price Target: n/a
Current: $6.08
Upside: n/a
Mar 3, 2025
Rated: Hold
Price Target: n/a
Current: $10.80
Upside: n/a
Oct 15, 2024
Reiterated: Buy
Price Target: ¥3,200
Current: ¥2,527
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: $6.40
Current: $3.35
Upside: n/a
Aug 22, 2024
Reiterated: Buy
Price Target: n/a
Current: $16.20
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $88.50
Upside: n/a
Mar 26, 2024
Reiterated: Buy
Price Target: $29.30
Current: $17.20
Upside: n/a
Nov 24, 2023
Reiterated: Buy
Price Target: $55
Current: $29.06
Upside: n/a
Nov 3, 2023
Reiterated: Hold
Price Target: $36 → $30
Current: $13.53
Upside: n/a
Oct 10, 2023
Reiterated: Buy
Price Target: €120.00
Current: €31.22
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $189
Current: $345.80
Upside: n/a